2m 2m 2m 2m 2m 2m 2m
ROCKET PHARMACTC (RCKT)
NASDAQ
$3.42-$0.05 (-1.44%)
Price as of Jun 23, 2026 7:24 PM EDT- $377.8MMarket Cap
- 31.56%1-Year Change
- BiotechnologyIndustry
ROCKET PHARMACTC (RCKT)
$3.42-$0.05 (-1.44%)
RCKT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.47 | ||
Change | +$0.11 (+3.28%) | ||
Open | $3.40 | ||
High | $3.63 | ||
Low | $3.39 | ||
Previous Close | $3.46 | ||
Volume | 2,077,103 | ||
30-Day Average Volume | 3,009,421 | ||
1-Week Change | 20.98% | ||
1-Month Change | 16.89% | ||
1-Year Change | 31.56% | ||
3-Year Change | -83.95% | ||
5-Year Change | -91.84% | ||
Fundamentals | |||
Shares Outstanding | 109.2M | ||
Total Assets | $285.4M | ||
Market Cap | $377.8M | ||
Enterprise Value | $329.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$47.6M | ||
Free Cash Flow | -$45.5M | ||
EBIT | -$47.1M | ||
EBITDA | -$45.5M | ||
Net Working Capital | $125.4M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | 1 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue